<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Jeffrey Holzbeierlein named physician-in-chief at KU

January 27, 2023

DOWNLOAD PDF TABLE OF CONTENTS

Jeffrey Holzbeierlein, the William L. Valk endowed professor and chair of urology at the University of Kansas Medical Center, was named physician in chief of The University of Kansas Cancer Center.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

KU Cancer Center and Health System receive $20M in new federal investments

The University of Kansas Cancer Center and the University of Kansas Health System received $20 million in new federal investments.

August 02, 2024

KU establishes four-state Heartland Consortium as part of All of Us Research Program

The University of Kansas Medical Center is establishing a Midwest consortium as part of the National Institutes of Health’s All of Us Research Program. KU Medical Center and its partners will receive $6.3 million in initial funding, with the potential to renew the award every year for four years.

September 15, 2023

Conversation with The Cancer Letter

KU Cancer Center receives $100 million for a research and outpatient building

The Sunderland Foundation has given The University of Kansas Cancer Center a $100 million gift to construct a cancer center building.

By Paul Goldberg

Guest Editorial

A Super Bowl LVII challenge: It’s Chiefs/KU vs. Eagles/SKCC

One city is famous for its cheesesteaks. The other—a known hotspot for some of the country’s best barbecue.

February 10, 2023

By Matthew Huesser and Christine Thomas